Related Experiment Video

Updated: Sep 30, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of

Dug Keun Lee1, Byung-Chul Kim, Isaac Yi Kim

  • 1Laboratory of Cell Regulation and Carcinogenesis, National Institutes of Health, Bethesda, Maryland 20892, USA.

The Journal of Biological Chemistry
|July 30, 2002
PubMed

Insights

Human papillomavirus (HPV) oncoprotein E7 targets Smad proteins, blocking TGF-beta signaling. This interaction is crucial for HPV-associated cervical cancer development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Virology

Background:

  • Human papillomavirus (HPV) oncoprotein E7 is linked to cervical cancer.
  • HPV-positive cells resist TGF-beta growth inhibition due to E7's effect on pRb.
  • The role of E7 in targeting Smad proteins, key mediators of TGF-beta signaling, is unclear.

Purpose of the Study:

  • To investigate if HPV oncoprotein E7 directly targets Smad proteins involved in TGF-beta signaling.
  • To determine E7's impact on Smad transcriptional activity and TGF-beta's growth inhibitory function.

Main Methods:

  • Examined E7's interaction with Smad proteins (Smad2, Smad3, Smad4).
  • Utilized confocal microscopy to confirm in vivo co-localization of E7 and Smads.
  • Assessed E7's effect on Smad3 binding to DNA using a canonical Smad DNA binding sequence.

Main Results:

  • HPV oncoprotein E7 significantly inhibits Smad transcriptional activity.
  • E7 blocks TGF-beta's ability to inhibit DNA synthesis in HPV-positive cells.
  • E7 constitutively interacts with Smad2, Smad3, and Smad4, co-localizing in vivo.

Conclusions:

  • HPV oncoprotein E7 directly interacts with and suppresses Smad-mediated signaling.
  • E7's disruption of Smad signaling pathways may contribute to the development of HPV-associated cervical cancer.
  • This study reveals a novel mechanism by which HPV oncoproteins promote carcinogenesis.

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells09:20

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

Published on: July 23, 2010

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...